The therapeutic potential of inhibitors of the trypanothione cycle
- 24 February 2002
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 11 (2) , 217-231
Abstract
There is an urgent need for new drugs in the treatment of human African trypanosomiasis, Chagas’ disease and leishmaniasis. This article provides an overview of current drugs, formulations and their deficiencies. Targets for the design of new drugs and the rational provided for targeting enzymes of the trypanothione cycle are described. Biochemical aspects of the cycle and the currently investigated target trypanothione reductase are discussed as are the several classes of inhibitors and their in vitro potencies. Evidence is provided for considering the tryparedoxins as a new target for antiprotozoal chemotherapy and a summary of glutathione-based inhibitors with significant in vitro activity is reported.Keywords
This publication has 96 references indexed in Scilit:
- 2- and 3-Substituted 1,4-Naphthoquinone Derivatives as Subversive Substrates of Trypanothione Reductase and Lipoamide Dehydrogenase from Trypanosoma cruzi: Synthesis and Correlation between Redox Cycling Activities and in Vitro CytotoxicityJournal of Medicinal Chemistry, 2001
- The Biochemical Basis of Arsenical–Diamidine Crossresistance in African TrypanosomesParasitology Today, 1999
- Novel polyamine derivatives as potent competitive inhibitors of Trypanosoma cruzi trypanothione reductaseBioorganic & Medicinal Chemistry Letters, 1995
- The mode of association of amphiphilic drugs in aqueous solutionAdvances in Colloid and Interface Science, 1995
- Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptorGeneral Pharmacology: The Vascular System, 1993
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992
- Interaction of a glutathione S‐conjugate with glutathione reductase Kinetic and X‐ray crystallographic studiesEuropean Journal of Biochemistry, 1984
- Photo-labelling of glutaredoxin from Escherichia coliBiochemical and Biophysical Research Communications, 1982
- Glutathione derivatives as inhibitors of glutaredoxin and ribonucleotides reductase from Escherichia coliFEBS Letters, 1982